VDR and age-related macular degeneration: Stimulation of the VDR in respective tissues results in reduced inflammation in dry eye disease, age-related macular degeneration (AMD), inhibition of retinal neovascularization, protection of RPE cells from oxidative damage and reduction of corneal wound scarring (37–46).